ArticleBMC cancer2022

CD4 and FOXP3 as predictive markers for the recurrence of T3/T4a stage II colorectal cancer: applying a novel discrete Bayes decision rule.

Yuki Nakagami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.